Project Grant R01NS143906
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$586K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Piscataway, NJ 08854, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $431,750 R21 project grant (CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders) to Rutgers, The State University of New Jersey to study the role of the RIPK3 protein in protecting neurons from excitotoxicity during Zika virus infection. The two-year project will use a combination of pharmacogenetics, imaging, molecular biology, and electrophysiology to investigate how RIPK3...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,503,949 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Rockefeller University. The grant, awarded on May 1, 2025, supports a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts to discover therapeutic targets for neurological diseases by studying...
The federal Project Grant award R15NS137207, valued at $389,851, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research at the Florida Institute of Technology (Florida TECH) to investigate the role of the RPM-1 signaling network in tau protein-related neurodegeneration using a C. elegans tauopathy model. The proposed research...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,830,581 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to The Johns Hopkins University. The grant supports in-depth characterization of the mechanism of action of a new macrocycle molecule called RAPIREON, which selectively activates the nuclease activity of the IRE1 protein in the unfolded protein response (UPR) pathway....
This federal Project Grant award, with the ID R35NS132231, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $885,128 grant supports research aimed at gaining a molecular-level understanding of the design principles governing somatosensation and nociception by membrane sensory receptor channels, as well as broader contextualization. The research, led...
This Project Grant award of $363,969 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders will support research to characterize the mechanisms by which thyroid hormone regulates HSV-1 latency and reactivation in neurons. The project aims to use computer-guided mutagenesis to generate chimeric viruses and investigate how thyroid hormone binding and neuronal excitability impact...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders provides $853,312 to Creighton University to research a novel therapeutic strategy targeting neuroinflammation for global cerebral ischemia associated with cardiac arrest. The primary objectives are to determine the pathological importance of the TREM1 receptor, elucidate the mechanisms by which...
This federal Project Grant award, with a total funding amount of $336,070.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, effective September 1, 2024, supports research conducted by Rutgers, The State University of New Jersey, to define and manipulate the gene regulatory networks that dictate the transition through senescence states. The research program aims to generate...
This federal Project Grant award of $364,448.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) focuses on investigating the neural functions of glycoprotein sialylation. The research aims to reveal sialylation-mediated mechanisms of glia-neuron coupling, elucidate the role of sialylation in promoting neuronal viability and resistance to oxidative stress, and characterize...
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $666,380 to Rutgers, The State University of New Jersey to scale up production of synchronized early postmitotic cortical interneurons (CINs) derived from human pluripotent stem cells. The goal is to develop a cell therapy for intractable temporal lobe epilepsy, with plans...